Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: A prospective, randomized-controlled trial

Acta Anaesthesiologica Scandinavica

Volumn 52, Issue 1, 2008, Pages 65-72

  Rex, S ^a   Schaelte, G ^a   Metzelder, S ^a   Flier, S ^b   De Waal, E E C ^b   Autschbach, R ^a   Rossaint, R ^a   Buhre, W ^c  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Cardiopulmonary bypass; Inhaled iloprost; Mitral valve surgery; Pulmonary hypertension; Pulmonary vascular resistance; Right ventricular ejection fraction; Right ventricular failure

Indexed keywords

GLYCERYL TRINITRATE; ILOPROST; MILRINONE; NITRIC OXIDE;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MALE; MITRAL VALVE REPAIR; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY ARTERY CATHETER; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADMINISTRATION, INHALATION; AGED; CARDIAC OUTPUT, LOW; CARDIOPULMONARY BYPASS; CATHETERIZATION, SWAN-GANZ; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MILRINONE; MITRAL VALVE INSUFFICIENCY; MONITORING, INTRAOPERATIVE; NITROGLYCERIN; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; STROKE VOLUME; VASCULAR RESISTANCE; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 37549057026     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2007.01476.x     Document Type: Article

References (33)

1. Fattouch K, Sbraga F, Bianco G et al. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement. J Card Surg 2005 20 : 171 6.
2. Riedel B. The pathophysiology and management of perioperative pulmonary hypertension with specific emphasis on the period following cardiac surgery. Int Anesthesiol Clin 1999 37 : 55 79.
3. Davila-Roman VG, Waggoner AD, Hopkins WE et al. Right ventricular dysfunction in low output syndrome after cardiac operations: assessment by transesophageal echocardiography. Ann Thorac Surg 1995 60 : 1081 6.
4. Mebazaa A, Karpati P, Renaud E et al. Acute right ventricular failure - from pathophysiology to new treatments. Intensive Care Med 2004 30 : 185 96.
5. Missant C, Rex S, Segers P et al. Levosimendan improves right ventriculovascular coupling in a porcine model of right ventricular dysfunction. Crit Care Med 2007 35 : 707 15.
6. Lowson SM. Inhaled alternatives to nitric oxide. Anesthesiology 2002 96 : 1504 13.
7. Olschewski H, Rose F, Schermuly R et al. Prostacyclin and its analogues in the treatment of pulmonary hypertension. Pharmacol Ther 2004 102 : 139 53.
8. Olschewski H, Rohde B, Behr J et al. Pharmacodynamics and pharmacokinetics of inhaled iloprost, aerosolized by three different devices, in severe pulmonary hypertension. Chest 2003 124 : 1294 30.
9. Olschewski H, Simonneau G, Galie N et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 2002 347 : 322 9.
10. Rex S, Busch T, Vettelschoss M et al. Intraoperative management of severe pulmonary hypertension during cardiac surgery with inhaled iloprost. Anesthesiology 2003 99 : 745 7.
11. Theodoraki K, Rellia P, Thanopoulos A et al. Inhaled iloprost controls pulmonary hypertension after cardiopulmonary bypass. Can J Anaesth 2002 49 : 963 7.
12. Theodoraki K, Tsiapras D, Tsourelis L et al. Inhaled iloprost in eight heart transplant recipients presenting with post-bypass acute right ventricular dysfunction. Acta Anaesthesiol Scand 2006 50 : 1213 7.
13. Kramm T, Eberle B, Krummenauer F et al. Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: effects before and after pulmonary thromboendarterectomy. Ann Thorac Surg 2003 76 : 711 8.
14. Kramm T, Eberle B, Guth S et al. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy. Eur J Cardiothorac Surg 2005 28 : 882 8.
15. Galie N, Torbicki A, Barst R et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The task force on diagnosis and treatment of pulmonary arterial hypertension of the European Society of Cardiology. Eur Heart J 2004 25 : 2243 78.
16. Godje O, Peyerl M, Seebauer T et al. Reproducibility of double indicator dilution measurements of intrathoracic blood volume compartments, extravascular lung water, and liver function. Chest 1998 113 : 1070 7.
17. Gessler T, Schmehl T, Hoeper MM et al. Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension. Eur Respir J 2001 17 : 14 9.
18. Vieillard-Baron A, Prin S, Chergui K et al. Echo-Doppler demonstration of acute cor pulmonale at the bedside in the medical intensive care unit. Am J Respir Crit Care Med 2002 166 : 1310 9.
19. Ludbrook J. Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc Res 1994 28 : 303 11.
20. Santini F, Casali G, Franchi G et al. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults. Int J Cardiol 2005 103 : 156 63.
21. Lowson SM. Inhaled alternatives to nitric oxide. Crit Care Med 2005 33 : S188 95.
22. Goldstein JA. Pathophysiology and management of right heart ischemia. J Am Coll Cardiol 2002 40 : 841 53.
23. Sitbon O, Brenot F, Denjean A et al. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin. Am J Respir Crit Care Med 1995 151 : 384 9.
24. De Wet CJ, Affleck DG, Jacobsohn E et al. Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery. J Thorac Cardiovasc Surg 2004 127 : 1058 67.
25. Lowson SM, Doctor A, Walsh BK et al. Inhaled prostacyclin for the treatment of pulmonary hypertension after cardiac surgery. Crit Care Med 2002 30 : 2762 4.
26. Haraldsson A, Kieler-Jensen N, Ricksten SE. Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmacodynamic study. J Cardiothorac Vasc Anesth 1996 10 : 864 8.
27. Hoeper MM, Olschewski H, Ghofrani HA et al. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group. J Am Coll Cardiol 2000 35 : 176 82.
28. Wilkens H, Bauer M, Forestier N et al. Influence of inhaled iloprost on transpulmonary gradient of big endothelin in patients with pulmonary hypertension. Circulation 2003 107 : 1509 13.
29. Schulze-Neick I, Li J, Reader JA et al. The endothelin antagonist BQ123 reduces pulmonary vascular resistance after surgical intervention for congenital heart disease. J Thorac Cardiovasc Surg 2002 124 : 435 41.
30. Olschewski H, Ghofrani HA, Schmehl T et al. Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group. Ann Intern Med 2000 132 : 435 43.
31. Gorlitzer M, Ankersmit J, Fiegl N et al. Is the transpulmonary pressure gradient a predictor for mortality after orthotopic cardiac transplantation? Transplant Int 2005 18 : 390 5.
32. Hoeper MM, Schwarze M, Ehlerding S et al. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. N Engl J Med 2000 342 : 1866 70.
33. Schermuly RT, Yilmaz H, Ghofrani HA et al. Inhaled iloprost reverses vascular remodeling in chronic experimental pulmonary hypertension. Am J Respir Crit Care Med 2005 172 : 358 63.